文献速递其他结缔组织病

稳定型未分化结缔组织病患者的疾病演变与器官损伤累积:一项长期单中心起始队列研究

Disease evolution and organ damage accrual in patients with stable UCTD: a long-term monocentric inception cohort.
PubMed 文献 · RMD Open · 2024-04-25

该研究回顾性分析141例稳定型未分化结缔组织病(sUCTD)起始队列,评估1、5、10年疾病演变与损伤累积。中位11年后11.3%患者演变为明确结缔组织病;27.3%至少记录到一项器官损伤。sUCTD无损伤10年概率为23%,显著低于年龄性别匹配的系统性红斑狼疮(SLE)患者的62%(p=0.015)。

要点

  • sUCTD中位11年后11.3%演变为明确结缔组织病。
  • 27.3%的sUCTD患者至少记录到一项器官损伤(SLICC/DI)。
  • sUCTD无损伤10年概率23%,SLE为62%(p=0.015)。

核心结论

  • 尽管影响显著低于SLE患者,长期UCTD仍可累积器官损伤并演变为明确的结缔组织病。

研究设计与样本

  • 回顾性纵向分析,纳入141例稳定型UCTD起始队列患者,在1、5、10年评估疾病演变与损伤累积。
  • 采用偏最小二乘(PLS)回归识别与1、5、10年随访损伤累积相关的基础变量。
  • 采用Nelson-Aalen分析与年龄、性别匹配的SLE队列比较损伤随时间的变化趋势。

主要发现

  • 11.3%的患者在首次症状出现后中位11年(IQR 6-25)演变为明确的结缔组织病。
  • 末次访视时,10%的患者使用糖皮质激素,6%使用免疫抑制治疗。
  • 27.3%的患者根据SLICC/DI评分至少记录到一项器官损伤(平均评分1.19±0.46)。
  • PLS分析中,诊断时年龄和首次症状时年龄与1年时损伤相关,未使用抗疟药和使用免疫抑制剂与5年时损伤相关。
  • 无损伤平均生存期在sUCTD为9.3年,在SLE为8.4年;无损伤10年概率在SLE为62%、在sUCTD为23%(p=0.015)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Undifferentiated connective tissue diseases (UCTDs) are systemic autoimmune conditions that cannot be diagnosed nor classified as defined CTD; the majority maintains an undifferentiated profile (stable UCTD, sUCTD) over time. Data on long-term outcomes of sUCTD are lacking. METHODS: Retrospective longitudinal analysis of an inception cohort of 141 patients with sUCTD.Disease evolution and damage accrual were evaluated at 1, 5 and 10 years. Partial least square (PLS) regression was used to identify the basal variables contributing to damage accrual at 1, 5 and 10 years of follow-up. Trend of damage over time was compared with a cohort of age-matched and sex-matched patients with systemic lupus erythematosus (SLE) by means of Nelson-Aalen analysis. RESULTS: 11.3% of patients evolved to a definite CTD after a median 11 years (IQR 6-25) from the first symptom. At last visit, 10% were on glucocorticoids and 6% on immunosuppressive therapy. In 27.3%, at least one item of organ damage was recorded according to the SLICC/DI score (mean score 1.19±0.46). At PLS analysis, age at diagnosis and age at first symptoms were related to damage at 1 year, not taking antimalarials and taking immunosuppressants were associated with damage at 5 years.The mean survival without damage was 9.3 years in sUCTD and 8.4 years in SLE. The 10-year probability without damage was 62% and 23% in SLE and sUCTD, respectively (p=0.015). CONCLUSIONS: Although less significantly impacted than in patients with SLE, in the long-term UCTDs can accumulate organ damage and evolve into defined connective tissue diseases.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Tani C, Trentin F, Parma A, et al. Disease evolution and organ damage accrual in patients with stable UCTD: a long-term monocentric inception cohort. RMD Open. 2024. PMID: 38670557. doi:10.1136/rmdopen-2023-003967

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。